Anakinra - Hamlet BioPharma
Alternative Names: IL-1 receptor antagonist - Hamlet BioPharma; IL-1RA - Hamlet BioPharmaLatest Information Update: 03 Feb 2025
Price :
$50 *
At a glance
- Originator Hamlet Pharma AB
- Developer Hamlet Pharma AB; Justus Liebig University Giessen
- Class Anti-infectives; Anti-inflammatories; Antibacterials; Antigouts; Antineoplastics; Antirheumatics; Recombinant proteins
- Mechanism of Action Interleukin 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Cystitis